CIK 0001816736 · Large accelerated filer
Disc Medicine, Inc.
Sign in to watch- Ticker
- IRON
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 851612845
- Phone
- (617) 674-9274
- Business address
- 321 ARSENAL STREET, SUITE 101, WATERTOWN, MA, 02472
- Former names
- Gemini Therapeutics, Inc. /DE, FS Development Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $14,489,047
- in 7 filings, $12.6M under 10b5-1 plans
Net −$14,489,047. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-07-09 | Quisel John D Chief Executive Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −34,800 | 115,375 | ||
| 2025-07-03 | Quisel John D Chief Executive Officer | Option exercise 10b5-1 | +5,200 | $9.86 | $51K | 167,028 |
| 2025-07-03 | Quisel John D Chief Executive Officer | Sale 10b5-1 | −5,200 | $55.09 | $286K | 161,828 |
| 2025-07-03 | Quisel John D Chief Executive Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,200 | 150,175 | ||
| 2025-06-27 | Savage William Jacob Chief Medical Officer | Option exercise | +29,659 | $9.86 | $292K | 86,384 |
| 2025-06-27 | Savage William Jacob Chief Medical Officer | Option exercise | +2,411 | $9.86 | $24K | 88,795 |
| 2025-06-27 | Savage William Jacob Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −29,659 | 6,375 | ||
| 2025-06-27 | Savage William Jacob Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −2,411 | 2,847 | ||
| 2025-06-16 | Franchi Jean M. Chief Financial Officer | Sale 10b5-1 | −2,000 | $52.26 | $105K | 67,530 |
| 2025-06-11 | White William Richard Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2025-06-11 | Ratcliffe Liam Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2025-06-11 | Nicholson Donald William Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2025-06-11 | GEMAYEL GEORGES Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2025-06-11 | Chin Mark Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2025-06-11 | Bitterman Kevin Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2025-06-11 | Ashiya Mona Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2025-06-06 | Savage William Jacob Chief Medical Officer | Sale 10b5-1 | −2,996 | $50.00 | $150K | 56,725 |
| 2025-05-20 | Savage William Jacob Chief Medical Officer | Sale 10b5-1 | −6,677 | $50.04 | $334K | 59,721 |
| 2025-05-02 | Savage William Jacob Chief Medical Officer | Sale 10b5-1 | −2,100 | $50.17 | $105K | 66,398 |
| 2025-04-07 | Quisel John D Chief Executive Officer | Option exercise | +7,000 | $1.01 | $7K | 161,828 |
Page 12 of 17 · 337 trades